Table 2.
Mean ( ± SE) developmental times (d) of various life stages of F1 generation A. gossypii produced from parents (F0) and longevity (d) and fecundity (d) of F0 generation treated with LC15 and LC30 concentrations of buprofezin for 72 h compared to the untreated control.
| Treatments | 1st instar | 2nd instar | 3rd instar | 4th instar | Pre-adult | Adult Longevity F1 | Adult Fecundity F1 | Adult Longevity F0 | Adult Fecundity F0 |
|---|---|---|---|---|---|---|---|---|---|
| Control | 1.85 ± 0.07b | 1.48 ± 0.07b | 1.32 ± 0.06b | 1.03 ± 0.02c | 5.68 ± 0.06c | 25.38 ± 0.68a | 35.17 ± 0.23a | 21.16 ± 0.61a | 28.86 ± 0.82a |
| LC15 | 1.97 ± 0.05b | 1.62 ± 0.06b | 1.47 ± 0.07b | 1.28 ± 0.05b | 6.33 ± 0.07b | 18.40 ± 0.48b | 28.30 ± 0.81b | 14.03 ± 0.61b | 18.03 ± 0.84b |
| LC30 | 2.17 ± 0.04a | 1.98 ± 0.06a | 1.88 ± 0.07a | 1.82 ± 0.07a | 7.85 ± 0.05a | 10.83 ± 0.55c | 12.27 ± 0.25c | 8.30 ± 0.67c | 9.01 ± 0.66c |
Different letters within the same column represent significant differences at P < 0.05 level (one-way ANOVA followed by Tukey HSD tests).